Skip to main content
. Author manuscript; available in PMC: 2021 Feb 9.
Published in final edited form as: J Parkinsons Dis. 2021;11(1):283–297. doi: 10.3233/JPD-202166

Table 2.

Brain Volume/Thickness Characteristics by PD Cognitive Phenotype and Non-PD peers

Variable PD Executive (n=25) PD Memory (n=35) PD Cognitively Well (n=56) Non-PD (n=62) p-value
Brain Volumes (cm3)
Total Intracranial 1699 ± 161 1395/2047 1711 ± 140 1435/2112 1650 ± 147 1263/1928 1623 ± 131 1343/1887 .02*
Ventricle Volume 54.45 ± 33.22 7.93/147.01 34.08 ± 18.08, 11.31/87.49 34.54 ± 16.14, 9.35/78.39 29.78 ± 14.12, 6.74/65.52 <.01*
Brain Volume 1101 ± 83.0 973/1283 1150±113.3 946/1526 1106 ± 99.87 805/1307; 1145 1091 ± 96.65 906/1306 <.01*
Total Gray Matter Volume 620.08 ± 50.76 514.26/745.92 635.48 ± 57.82 522.22/826.68 619.62 ± 50.25 459.54/714.02 619.06 ± 48.24 523.85/734.14 <.01
Cortex Volume 458.29 ± 40.87 373.42/555.65 473.90 ± 46.22 387.58/627.46 458.73 ± 39.87 343.91/551.97 459.48 ± 38.89 388.29/558.97 <.01
Subcortical Grey Volume 53.96 ± 3.88 47.83/61.31 56.85 ± 5.69 45.90/71.68 54.81 ± 5.26 41.18/64.54 54.40 ± 4.80 46.03/66.11 .02*
White Matter Volume 454.83±37.51 375.51/534.85 484.07±59.45 401.51/667.24 460.09±53.91 329.04/612.48 446.70±53.02 340.65/581.36 <.01*
Hippocampus Volume 3.68±0.33 3.17/4.31 3.93±0.44 2.97/5.07 3.86±0.38 3.12/4.86 3.87±0.43 2.87/4.94 <.01*
Caudate Volume 3.55±0.64 2.61/5.60 3.54±0.64, 2.41/6.03 3.43±0.52 2.39/4.64 3.44±0.53 2.43/5.41 .67
Putamen Volume 4.42±0.35 3.76/5.10 4.66±0.73 3.58/7.28 4.43±0.67 2.70/5.84 4.64±0.53 3.50/5.94 .02
Thalamus Volume 6.75±0.64 5.51/8.05 7.07±0.76 5.38/8.79 6.91±0.79 4.73/9.59 6.61±0.67 5.21/8.32 .04
Cortical Thickness (mm)
ERC Thickness 3.30±0.27 2.53/3.75 3.32±0.24 2.86/3.74 3.32±0.23 2.77/3.86 3.36±0.4 2.80/3.84 .64
DLPFC Thickness 2.34±0.10 2.11/2.47 2.36±0.09 2.16/2.54 2.35±0.09 2.17/2.56 2.36±0.09 2.11/2.5 .83

All values reported as Mean±SD, Min/Max. All volumes reported in cm3; thickness is presented in mm. ERC=Entorhinal Cortex. DLPFC=Dorsolateral Prefrontal Cortex.

*

indicates significant difference between PD phenotypes after controlling for disease duration.